Golfer says he ‘overdosed' on creatine during BMW Championship
World No. 17 Griffin said that he 'started getting super shaky' and 'felt like I had tremors' on Sunday after accidentally swallowing a large amount of the supplement.
Creatine 'contributes to rapid energy production and may enhance power or speed bursts requiring short periods of anaerobic activity,' according to Harvard Health, and usage of the supplement is common among gym enthusiasts as there is evidence it 'can hasten muscle recovery after strenuous exercise.'
'I've taken it on the golf course before. It's fine,' Griffin said, per the PGA Tour.
'I started taking it after my second shot, and I accidentally swallowed one of the big rocks in my water bottle. I've never overdosed on creatine before, but I think I did in the moment because I didn't really drink any water after that. I basically just inhaled a snowball,' the two-time PGA Tour winner explained.
Griffin said that he usually takes 15mg of the supplement daily, but on this occasion, he estimates he accidentally ingested that amount at one time.
'I was physically shaking like I've never felt before,' Griffin said. 'And I don't normally miss a lot of short putts. It was really a weird situation.'
The golfer said that his caddie intervened by making him drink water and calming him down.
Griffin was six over par for the first three holes – carding a triple-bogey, double-bogey and bogey – and the golfer thought about withdrawing from the tournament, but after that, he said the physical effects started to wear off. He then made seven birdies and signed for a one-under 69, finishing tied for 12th in an impressive comeback.
'It was probably more just a little bit flustered. I was fine after the second shot on two. And then it was – I felt good so I went about my day and got it back to under par,' he said.
The golfer said he will be limiting his intake of the supplement in future, calling the events of the day a 'pretty crazy story.'
'I don't think I'll be taking too much creatine in the future. I will take it, but not in the amount that I probably did on the golf course, which wasn't probably a healthy amount.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Breaking down the 10 Detroit Lions rookie performances vs. Dolphins
As the preseason rolls onward, the Detroit Lions are going to use every chance that they can get to evaluate the backend of their roster. Once again, the team's 2025 rookie class impressed. A total of 10 first-year players suited up in the preseason matchup against the Miami Dolphins, and many of them made quite the case for a roster spot once the regular season begins. Undrafted wide receiver Jackson Meeks put on a show for the second week in a row. The rookie who played for Georgia and Syracuse made the first reception of the game and went on to finish the day with a team-high 93 yards as well as a touchdown. He was used heavily on special teams as well, taking the field for nearly half of the unit's snaps. He did make one rookie mistake, getting flagged for an illegal shift later in the game. Third-round pick Isaac TeSlaa also had himself a day. The Michigan native was another big contributor on offense, hauling in four receptions for 41 yards and a trip to the endzone. He had some opportunities that were missed as well, including dropping an overthrown pass from Kyle Allen and having a first-down reception called back due to an illegal forward pass penalty. Dominic Lovett wasn't as productive on offense as he was in the previous preseason outings. His biggest contribution in this game came on special teams as a gunner. In the third quarter, he scooped up the ball off of a muffed punt by the Dolphins and returned it within a few yards of the endzone—although you aren't allowed to advance a muffed punt. Zach Horton got a significant amount of time on offense, taking the field for over 70% of the team's snaps. He displayed even more versatility than he has in the other preseason games, being used as an in-line tight end, fullback, slot receiver, and even lining out wide on a few plays. He caught his first two passes of his career, totaling 15 yards. He, too, couldn't escape the eyes of the referees, and was called for a holding penalty that negated a big run from Craig Reynolds. With many new faces in Detroit's secondary, undrafted cornerback Tyson Russell didn't make much of an impact as he had the week prior, but still recorded three tackles. Offensive lineman Mason Miller made the move from tackle to guard in this game, most likely due to the plethora of injuries that Detroit has in that position group right now. He played much better than he had earlier in the preseason, and even earned a shoutout from the broadcast crew for his blocking on long run from Jacob Saylors. Undrafted rookies Ian Kennelly and Keith Cooper both were named starters for this game and played on defense for a majority of Detroit's snaps. Cooper flashed some positional versatility, playing both as an interior defensive lineman and edge rusher. Wide receiver Jakobie Keeney-James had a quiet day, being targeted once but not recording any stats. Fan-favorite Ahmed Hassanein only played 10 snaps for Detroit before sustaining an injury that will cause him to miss some time this season. The following draft picks did not play: Tyleik Williams, Tate Ratledge, Miles Frazier (PUP), Dan Jackson (IR)
Yahoo
26 minutes ago
- Yahoo
First PRIZM Study Participant Enrolled in Tisento Therapeutics' Open-Label Extension Study in MELAS
Participants Who Complete Treatment in Global Phase 2b PRIZM MELAS Study Are Eligible to Enroll CAMBRIDGE, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Tisento Therapeutics today announced that the first participant has enrolled in the company's open-label extension study in MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes). The extension study (NCT06961344) is evaluating the long-term safety and tolerability of zagociguat in individuals with MELAS who complete treatment in the global Phase 2b PRIZM study, which is expected to complete screening in the next months. The extension study is intended to provide uninterrupted access to zagociguat for clinical trial participants for up to two years and evaluate the long-term safety of zagociguat. 'We're pleased to reach the important milestone of enrolling the first PRIZM study participant into our open-label extension study,' said Peter Hecht, Ph.D., chief executive officer of Tisento. 'Enthusiastic engagement by MELAS patients and physicians is powering momentum in our development program, and we look forward to completing PRIZM enrollment in the next few months.' The PRIZM study is actively enrolling in the U.S., Canada, Australia, United Kingdom, Italy, and Germany, and interested individuals are encouraged to discuss participation with their physician. PRIZM is evaluating the impact of zagociguat treatment on fatigue, cognitive performance, and other key aspects of MELAS. The clinical outcome assessments and endpoint strategy for the PRIZM study were informed by Tisento's interview study in which individuals living with MELAS described the symptoms and impacts of the disease that are most important to them. Participants who complete treatment in PRIZM have the opportunity to enroll in the open-label extension study. About the PRIZM Study PRIZM – a Phase 2b Randomized, Placebo-Controlled Trial Investigating Zagociguat in MELAS – is evaluating the efficacy and safety of oral zagociguat 15 mg or 30 mg compared to placebo when administered once-daily for 12 weeks in participants with genetically and phenotypically defined MELAS. The PRIZM study has a crossover design, with two 12-week treatment periods separated by a 4-week washout period. All participants will receive zagociguat during one of the 12-week periods and placebo during the other. Participants who complete treatment in the study have the opportunity to enroll in an open-label extension study. The global PRIZM study is now enrolling approximately 44 participants at mitochondrial disease centers of excellence in the U.S., Italy, Germany, United Kingdom, Australia, and Canada. For more information, please visit or (NCT06402123). Interested individuals can also reach out to their physicians for participation details. About Zagociguat Zagociguat is a once-daily, oral, clinical-stage investigational medicine with potential to positively impact both peripheral and central nervous system manifestations of mitochondrial diseases. Zagociguat stimulates soluble guanylate cyclase (sGC), an enzyme that is found in virtually every cell in every tissue of the body and is part of a system of cellular mechanisms that control critical physiological functions including neuronal function and blood flow. A first-in-class, brain-penetrant sGC stimulator, zagociguat is hypothesized to rebalance dysregulated cellular pathways in MELAS. By restoring cellular functions that support mitochondria, zagociguat may help restore mitochondrial energy production and physiological function. In a Phase 2a study in patients with MELAS, zagociguat exhibited a favorable safety profile, exposure throughout the body including in the central nervous system, and improvements in neuronal function, mitochondrial function, and blood flow in the brain. Zagociguat is currently being evaluated as a treatment for MELAS in the Phase 2b PRIZM study. Zagociguat received Fast Track designation from the U.S. Food and Drug Administration for the treatment of MELAS. Fast Track is a process designed to facilitate the development and potentially expedite the review of medicines to treat serious conditions and fill an unmet medical need, with the goal of getting important new drugs to patients earlier. For more information, visit About Tisento Therapeutics Tisento Therapeutics, a privately held biotech company, is developing novel medicines to treat diseases with significant unmet need, beginning with MELAS and other genetic mitochondrial diseases. Ti sento means 'I hear you' in Italian; our approach to innovation begins with listening to patients and then channeling what we learn into decisive actions that shape our research and clinical programs. Tisento is guided by a high-caliber internal team of biopharma veterans and an extensive external network of expert physicians, patient advocacy groups, researchers, industry-leading vendors, and other close collaborators who are partners in our mission to develop meaningful treatments for mitochondrial diseases. Learn more at our website, or connect with us on LinkedIn, Facebook, X (@tisentotx), or Bluesky. Contact Tisento Media RelationsJessi Rennekamp, Astrior CommunicationsEmail: jessi@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
26 minutes ago
- Yahoo
This Advice From Economics Might Be The Answer To Your Parenting Burnout. Here's Why.
When my wife and I brought our first child home from the hospital, we planned on diligently following all of the expert recommendations regarding his care: He would breastfeed exclusively and sleep in a bassinet beside our bed, on his back, in a properly ventilated room. We had read about SIDS and would take every possible precaution. What could be more important that preventing harm from coming to our child? Almost immediately, however, we ran into trouble. Our baby stopped peeing. He was dehydrated and hungry, somehow, although he spent pretty much all day at my breast. So we feed him some infant formula using a medicine dropper, which he lapped up hungrily, sending me into a shame spiral that took months of therapy to crawl out of. But at least with the supplementary formula we were able to keep him happily fed. Related: The second problem sent us into a territory that was even more mortifying. In spite of the fact that my breasts were only partially functional, the baby was extremely attached to them. As in, he would only sleep if they were right there, right beside him, skin to skin with his tiny cheek. Every time he feel asleep while nursing and unlatched his little rosebud lips, I moved as stealthily as possible to try to get him into the bassinet. But more often than not, he woke and started crying. And even if I could get him to lie in the bassinet, it often didn't last long. The end result was that I spent a lot of time nursing him in the chair, and, in my desperation and exhaustion, I often fell asleep. My wife could tell, just by looking at us, that this was not a safe situation. Since it wasn't possible to get him into the bassinet, we just cleared our bed of blankets and pillows and let him sleep where he wanted to, right next to my body. We didn't tell anyone. We had been taught that bed-sharing with a baby was deadly, so we certainly weren't going to admit to doing it. This was all back in 2009, before economist Emily Oster began publishing her bestselling books, in which she brings a unique, data-driven perspective to the art of parenting. In her second book, 'Cribsheet,' she explains how holding up the ideal infant sleeping arrangement as the only permissible option can actually lead parents to put their babies in more danger. Because although it is safest to have baby sleep on a separate surface, it is much more dangerous to sleep with a baby on a sofa or armchair. Sixty-seven times more dangerous. Though it wasn't a best-case scenario that the baby wasn't in the bassinet, he was a lot safer sleeping next to me on the mattress instead of in the recliner. Infant sleep, Oster writes, is one example of a scenario in which we might benefit from considering what she calls 'second best' parenting. It is a term she borrows from economics. 'When we are giving advice in parenting, we tend to be absolutist: There is the best option and then everything else,' Oster told HuffPost, She has used the term 'outer darkness' to refer to everything else — as in, if it's not the best option, it's all equally bad and scary. But this all-or-nothing approach doesn't apply well to infant sleep, where we clearly have a first best option (bassinet/crib in same room as parent) followed by a second best option (on a clear, flat sleeping surface next to the nursing parent) and then, way, way down, the 67th best option of a desperate mother accidentally falling asleep in an armchair while holding the baby because she has been told that under no circumstances should she consider bringing the baby into her bed. 'The idea of 'second best' is to recognize that within the category of 'other options,' some are better than others. The second best is the best option that we can achieve,' Oster said. She thinks that this can be a useful framework for other parenting choices, too, such as what to feed our children. 'We're told the best snack for our kids is, say, a whole apple and a glass of water. But what if your kid doesn't eat that? We don't help people pick well among the options their child will eat. You'd be forgiven for thinking that once you're going to applesauce, you might as well give a pile of cookies. But actually those aren't the same.' Believing that there is only one right way and the rest are wrong sets us up to see only black and white when actually there are so many shades of gray. 'When we tell people that it's the 'best or the rest,' we do not allow for them to choose smartly among the rest,' Oster said. In addition to not choosing well, this thinking makes people feel badly about how they're parenting. 'When we tell people they aren't doing their best, that disempowers them. And no one parents well from a place of shame,' Oster added. Finding Other Good Options Beyond Perfect The advantage of referring to 'second best' is that, with the word 'best,' parents are left with space to take pride in their parenting. A silver or bronze medal is still a win, after all. The argument that Oster is making is similar to that of 'good enough parenting,' an idea popularized in the 1950s by Donald Winnicott. Parenting coach Kristene Geering told HuffPost that this is the framework she uses with parents. 'It's based on the notion that there is no such thing as perfect,' Geering explained. 'Part of being human is that there are challenges, there are times when there's no clear or easy path (which is also how we learn). There is no 'best.' You take what information you have, make a decision based on that and then you learn as you go along.' Geering thinks this dovetails nicely with Carol Dweck's 'growth mindset,' in which as we learn more, we do better. Geering said she often tells families that 'we're all doing the best we can with what we have' and advises, 'Learn from your mistakes, repair as you go, and show your children how to hold compassion for yourself and those around you.' She likes the 'good enough' phrasing because it makes room for the idea that there are many different options that might be 'bests' for different families dealing with different circumstances. Geering agrees with Oster that it's important to move parents out the space of 'all is lost,' where they may get trapped in their shame. She said that where she works in Silicon Valley, 'I see a lot of parents fall into this trap of trying to be 'perfect' ... and then researching themselves into a state where they're almost frozen with indecision.' With an endless amount of information readily available, this isn't an uncommon place for parents to land. 'I've fallen into this trap as well,' Geering admitted. 'Things like which school to attend, which activity to sign up for... it's really overwhelming.' Make Peace With Your 'Good Enough' Using a 'second best' or 'good enough' mindset doesn't come naturally to people raised in a culture of competition. But sooner or later, all parents are faced with a scenario that challenges expectations of perfection. For Geering, a clear example of this in her own family was pandemic schooling. 'I watched my own kids struggle on 'Zoom school,' to the point where it was clear this would never work for them. So I pulled them, and we did homeschool for a year... while my husband and I both worked full time. Was it perfect? Nope. Was it 'second best'? I have no idea.' Her kids are 'still catching up on math,' she said, although they also 'gained a lot of skills in independence.' 'Instead of beating myself up on all the math they missed out on, I looked at it from the point of view that I was doing the best I could in really awful circumstances. And I looked at all the moms in my friend groups and the parents I was working with, and I saw everyone making different decisions, based on their specific circumstances. Absolutely no one did the 'best' thing... because there was no 'best' thing.' Whether you think of it as 'second best' or 'good enough,' parenting within this framework, as opposed to one in which there is only one right option for all families, makes room for you to give yourself some grace. An added benefit of letting go of a perfection-or-nothing mindset is the weight that this takes off of our kids. If we 'show them how to repair the relationship when we mess up and share our learning process with them,' Geering said, 'it lets them be compassionate with themselves, learn from their mistakes, create authentic and meaningful relationships with others, and have a growth mindset as their default throughout life. That's pretty powerful stuff.' Related... Parents Are Lying About Where Their Babies Sleep At Night. Here's Why That's A Problem. What Second-Time Parents Wish They Didn't Stress About The First Time Around This 1 Thing May Be Wearing Parents Out Everywhere
